Similarly, as shown in Fig. 2B, we found that the levels of plasma exosomal versican in the NSCLC group were greater than those in the benign disease and healthy control groups, and the difference was statistically significant (one-way ANOVA, F = 9.907, P < 0.001). The gene discussed is VCAN; the disease is non-small cell lung carcinoma.